# A Study to Investigate the Safety, Tolerability and Pharmacokinetics of TESP-0401 in Healthy Participants

> **NCT07658638** · PHASE1 · RECRUITING · sponsor: **Tes Pharma S.r.l.** · enrollment: 68 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** TESP-0401
- **DRUG:** Placebo
- **DRUG:** TESP-0401
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07658638
- **Lead sponsor:** Tes Pharma S.r.l.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-08
- **Primary completion:** 2027-03-03
- **Final completion:** 2027-03-03
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2026-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07658638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07658638, "A Study to Investigate the Safety, Tolerability and Pharmacokinetics of TESP-0401 in Healthy Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07658638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*